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cultured BALB/c epidermal Langerhans cells express high 
levels of the costimulatory molecule B7 on their surfaces 
relative to levels expressed on fresh Langerhans cells. Quan-
citation of relative amounts of B7 mRNA in fresh epidermal 
cells and cultured epidermal cells following amplification ?f 
rnRNA signals via reverse transcriptase-polymerase cham 
reaction, hybridization of PCR products with radio labeled 
internal oligonucleotide probes, resolution of hybrids in 
!lon-denaturing polyacrylamide gels, and detection by auto-
radiography revealed dramatically (approximately one thou-
sandfold) higher levels of B7 mRNA in cultured epidermal 
cells (10 - 40% I-A +) as compared with fresh epidermal cells 
(1- 4% I-A+). Levels ofB7 mRNA in cultured epidermal cells 
P revious studies demonstrated that Langerhans cells (LC) become potent accessory cells after culture in GM-CSF containing media for brief periods [1,2] . The increased accessory cell activity of cultured LC (cLC) relative to fresh LC (fLC) probably reflects increased expression of 
major histcompatibility complex antigens [3,4] and costimulatory 
molecules [5], and may mimic changes that occur in LC as they 
migrate from skin to regional lymph nodes after epicutaneo~s anti-
gen exposure ill "illo [6] . Several potentially important costlm~la­
tory and/or adhesion molecules including intercellular adheSIOn 
molecule 1 (rCAM-1) [5], lymphocyte function - associated antigen 
3 (LFA-3) [7J, and B7/BB1 l8] have been identified on the cell 
surfaces of LC and have been implicated as important determinants 
of the potent accessory cell activity of cLC and other dendritic cells 
[9}. Recent studies have emphasized the central role that B7 (ex-
pressed on the surfaces of accessory cells) plays in the activation. of 
naive CD4+ T cells [101, and in the avoidance of antigen-speCIfic 
clonal anergy [11,12] via engagement of the T-cell co-receptors 
CD28 [13,14J and CTLA-4 [15]. 
Although several novel approaches to treatment or prevention of 
allograft rejection [16,17] and experimental neoplasia (18,19] have 
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were also substantially greater than those detected in a refer-
ence B lymphoma cell line (CH-l). Analysis of B7 mRNA 
expression in subpopulations of cultured epidermal cells 
demonstrated that essentially all of the B7 mRNA was 
present in Langerhans cells; cells bearing I-A and CD45 anti-
gens. Cultured keratinocytes did not contain appreciable 
amounts of B7 mRNA. These results are consistent with 
previous data regarding surface expression of B7 by cLC and 
also demonstrate that fLC are essentially devoid of B7 
mRNA and surface protein. Key words: CD28/CTLA-4/ 
costimulatory molecules/accessory cells. ] Invest Dermatol 
101:883-886, 1993 
already evolved from studies ofB7 and its role in T-cell activation, 
regulatory mechanisms that control expression of B7 by accessory 
cells h~ve not been extensively studied. Since we began our studies 
regardll1g B7 expression by murine LC, it has been demonstrated 
that 1) murine cLC stain more intensely with the B7 -binding fusion 
protem CTLA4Ig than fLc [8), and 2) CTLA4Ig inhibits the acces-
~ory cell activity of cLC [8]. Symington et aJ reported similar results 
111 a study ofB7 expression by human LC, and also suggested thatB7 
mRNA was present in both fi..C and cLC [20). The studies detailed 
here employ a sensitive polymerase chain reaction (PCR)-based 
technique to quantitate mRNA levels and demonstrate that al-
though B7 mRNA is abundant in cLC, fresh murine EC (LC and 
keratinocytes) lack appreciable B7 mRNA. Our results indicate that 
significant.amounts of B7 mRNA and protein are not expressed in 
110rmal.ul1lnflamed murine epidermis, and suggest that the level of 
expressIon of B7 by LC is determined by B7 mRNA levels. 
MATERIALS AND METHODS 
Antibod~es, Fusion Proteins, and Flow CytOlnetry CTLA4Ig [1 5] 
and the mel evant control L6 (a murine-human fusion IgGt [15]) were 
proVided by Peter Linsley (Bristol-Myers Squibb, Seattle, WA). Mouse 
monoclonal antibody (MoAb) MK-D6 (anti-I-Ad) and an irrelevant IgG:z, 
control were purchased from Becton Dickinson (Mountain View, CAl . Rat 
MoAb 53-6.72 (anti-CDB, IgG:z,) YN/ 1.7.4 (anti-ICAM-1 [C054j, 
IgG:z,), MS/114.5.2 (anti-I-Ad, anti-I-Ed, IgG2b ), and Ml/89.18.7.HK (antt-CD45, IgG2b ) were obtained from the American Type Culture Col-
lectl.on (Rockville, MO). Biotil1-conjugat;d goat anti-human IgG [(Fab'h j, 
blO~m-cOl~ugated goat anti-rat IgG [(Fab h), and R-phycoerythrin strepta-
vldll1 were purchased from T AGO (Burlington, CAl. Fluorescein 
isothiocyanate - monoclonal rat aJ1ti-mouse Ig (K c1ujn speciEc) was ob-
tained from Zymed (San Francisco, CAl. EC were stained for simultaneous 
expressiollofl-A antigens and ICAM-1 as described [5]. Expression oEB7 on 
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LC (I-A+ cells) and KC (I-A- cells) was similarly evaluated substituting 
CTLA4Ig (or the irrevelant fusion protein L6) and biotin-conjugated goat 
anti-human IgG for YNjl .7.4 and biotin-goat anti-rat IgG. CTLA4Ig and 
L6 were used at Sllgjml. 
Preparation of Murine Epidermal Cells and Epidermal Cell Subp-
opulations Female BALBjc (H_2d) mice were obtained from Harlan 
Sprague Dawley (Frederick, MD) and used at 8-12 weeks of age. Fresh and 
72-h cultured EC were prepared from BALBjc ear skin by limited trypsini-
zation as previously described [21] . In some experiments, cEC were depleted 
of, and enriched for, cLC using rat MoAb and sheep anti-rat IgG-coated 
magnetic beads (Dynabeads M-4S0, Dynal, Oslo, Norway). cEC were incu-
bated with saturating amounts of the indicated rat MoAb for 1 h at 4°C, 
washed, and incubated with Dynabeads (approximately 20 beads per cLC) 
for 30 min at 4 ° C. Cells and beads were mixed continuously using a tube 
rotator. Bead-adherent and nonadhercnt cells were separated from each 
other with a magnet (Dynal) and RNA was prepared as described below. 
Quantitation of mRNA Using Reverse Transcriptase (RT)-
PCR Relative amounts of B7, I-AD' chain, and p-actin mRNA present in 
epidermal cells were quantitated using a modification of a previously de-
scribed method [22]. Briefly, total RNA was isolated from epidermal cells 
using acid guanidinium isothiocyanate/phenol (RNAzol B) (Biotex Labora-
tories , Houston, TX) and chloroform, and quantitated spectrophotometri-
cally. RNA was reverse transcribed and cDNA was amplified using a Gene-
Amp RNA PCR kit (Perkin Elmer Cetus, Norwalk, CT) in accordance with 
the manufacturer's instructions except that primer concentrations (3' for 
reverse transcription and 3' plus S' for PCR) were adjusted to 111M. After 
reverse transcription, cD N As were amplified during 20 - 2S cycles (20 cycles 
for p-actin and 2S cycles for B7 and I-All' chain) ofpCR ina GeneAmp PCR 
System 9600 thermal cycler (Perkin Elmer Cetus) with denaturation at 
9S0C for 1 min, annealing at SS OC for 1.2S min and polymerization at72°C 
for 2 min. Reagent grade primers were obtained from Synthecell (Rockville, 
MD). Primer and probe sequences for p-actin and I-AD' chain were as previ-
ously reported [22]. B7 primers were designed based on the published se-
quence for murine B7 [23] (5' B7 primer, 5'CCCGAGTATAAGAACCG-
GAC;3' B7 primer, S'CACAAGTGTGTTCTTGCTATC). These primers 
result in a 483-bp PCR product corresponding to nucleotides S17-999 of the 
1720-bp murine B7 cDNA sequence [23]. 
PCR products were quantitated as previously described [22]. Briefly, PCR 
products were hybridized to radiolabeled internal oligonucleotide probes, 
resolved in nondenaturing polyacryamide gels, and detected by autoradiog-
raphy. Densitometry was performed using an optical scanner (Microtek 
300FS, Torrence, CAl and Image 1.36 software (NIH, Bethesda, MD). The 
probe for B7 mRNA was designed based on the published B7 sequence [23] 
and corresponds to nucleotides 77S-809 (B7 probe, S'CGCTT-
CTCTTGGTTGGAAAATGGAAGAGAATTACC). 
RESULTS 
Expression of ICAM-l and B7 by Fresh and Cultured 
LC Previous studies demonstrated that murine cLC express much 
higher levels of ICAM-l [5] and B7 [8] than £l...c. We stained 
BALB/c fEC and cEC for simultaneous expression of I-A antigens 
and ICAM-l (or B7) using the rat MoAb YNl/1.7.4 (or the fusion 
protein CTLA4Ig). Cultured LC expressed levels of ICAM-l and 
B7 > fiftyfold higher than levels of the corresponding antigens on 
£l...C; little if any B7 was identified on £l...C, or fresh or cultured 
keratinocytes (T. A. Borkowski and M. C. Udey, unpublished ob-
servations). 
Relative mB7 mRNA Levels in Fresh and Cultured EC To 
assess the relationship of B7 surface expression to mRNA levels in 
cLC we employed quantitative RT -PCR [22]. B7 specific sense and 
anti-sense primers and an internal oligonucleotide probe were de-
signed based on the published sequence of murine B7 [23]. Condi-
tions allowing the amplification and detection of an appropriately 
sized PCR product complementary to the internal B7 probe in 
CH-l cells, a B-lymphoma cell line known to contain B7 mRNA 
[23]' were identified. Varying amounts of RNA from CH-l cells, 
fEC, 72-h cEC, PAM212 cell s (transformed murine keratinocytes), 
and L cells (transformed murine fibroblasts) were subjected to RT-
PCR using B7 and p-actin primers. PCR products were hybridized 
to excess amounts of radiolabeled internal probes, resolved in non-
denaturing gels, and detected by autoradiography. 
Data presented in Fig 1 demonstrate that cEC contain readily 
detectable B7 mRNA. The intensity of the B7 signal derived from 
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20 ng/ml cEC RNA was greater than that derived from reactions 
initiated with concentrations of CH-l RNA a thousandfold higher. 
Little if any B7 signal was identified in RNA prepared from fEC , 
transformed keratinocytes, or fibroblasts, although p-actin signals 
were readily identified in each of these samples. Note that at the 
highest concentrations of cEC RNA tested, the intensity of the band 
corresponding to the appropriately sized B7 PCR product decreased 
and irrelevant bands appeared. 
Quantitation of mB7, I-All, and p-Actin mRNA Levels in 
Cultured EC Cultured BALB/c EC are comprised of 10-40% 
cLC; the vast majority of the remaining cells are keratinocytes. To 
interpret the results of cell-depletion studies designed to identify the 
cell of origin of the B7 mRNA signal, it was necessary to first define 
conditions that allowed relative quantitation of I-All chain mRNA 
(chosen as a marker for LC) and p-actin mRNA (found in both LC 
and keratinocytes). We defined conditions that resulted in direct 
(log-linear) relationships between the amounts of total cEC RNA 
added into the RT-PCR reaction tubes and the intensities of the 
mRNA-derived signals using primers and probes specific for B7, 
I-All and p-actin (M. G. Lee and M. C. Udey, unpublished observa-
tions). Conditions expected to result in signal intensities that fell on 
the linear portion of each curve were chosen for subsequent experi-
ments. 
LC Contain All of the B7 mRNA in Cultured EC Depletion 
of cells bearing class II major histocompatibility complex and CD45 
antigens from cEC with appropriate rat MoAb and sheep anti-rat Ig 
coupled to magnetic beads resulted in the coincident loss of mRNA 
signals for I-All chain and B7 (Fig 2); depletion of CD8+ cells had 
no effect on either signal. RNA isolated from class II major histo-
compatibility complex and CD45 antigen - enriched preparations 
in the same experiment were enriched in mRNA encoding I-AU' 
chain and B7 (compare with B7 mRNA-derived signals observed 
with 1250 ng/ml cEC RNA [Fig 1 D. Cultured keratinocytes (de-
pleted of contaminating LC by extensive washing) also lacked B7 
and I-All chain mRNA (Fig 2). These results demonstrate that cLC 
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Figure 1. Cultured epidermal cells contain abundant mB7 mRNA. Vary-
ing amounts of total RNA from the ce lls indicated were subjected co PCR 
(with and without RT) using primers specific for mB7 and p-actin. PCR 
products were hybridized to radiolabeled internal oligonucleotide probes, 
resolved in non-denaturing gels and detected by autoradiography. Note that 
the amount of specific mB7 PCR product decreases when high levels of total 
RNA from cEC are added into the reaction tubes. Fresh EC were comprised 
of 1.9% I-A+ cells; cEC contained 34.9% I-A+ cells. 
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Figure 2. Langerhans cel ls contain all of the m137 mRNA present in cul-
tured epidermal cells. RNA was isolated from cEC (Ialle 1), I-A- cEC 
(:S 0.3% I-A+; lalle 2), CD45- cEC (:5 0.5% I-A+; latlc 3), CDS- cEC 
(10.2% I -A+; lalle 4), cEC enriched for I-A+ cells (Ialle 5), cEC enriched for 
CD45+ cells (Ialle 6), and cKC (:5 0.1 % I-A +; lalle 7) and relative amounts of 
rnRN As encoding m137, I-Aa, and p-actin in EC subpopulations were deter-
mined as described in Materials alld Methods. Tota l RNA concentrations in 
the peR reaction tubes were 125 ng/ml, 2 .5 ng/ ml, and 0.16 ng/ml for 137, 
I-Aa, and p-actin, respectively. p-Actin signals derived from samples sub-
jected to PCR in the absence (a) and in the presence of (b) ofRTare shown. 
contain essentially all of the B7 and I-Aa chain mRNA present in 
cEC. 
DISCUSSION 
The central role that engagement of CTLA-4 and CD28 on T cells 
by B 7 expressed on accessory cells plays in T-cell activation is we!1 
documented. The potent accessory cell activity of cLC and thelr 
phenotypic and functional relationship to other dendritic cells has 
also been extensively studied. Likely determinants of LC and den-
dritic cell accessory cell activity include levels of class I and class II 
major histocompatibili ty complex antigens and costimulatory and/ 
or adhesion molecules such as ICAM-1 , LFA-3, and B7. Recent 
studies suggest that B7 is perhaps the most important of these co-
stimulatory molecules. This view is consistent with the observation 
that LC are the only epidermis-derived cells that effectively present 
nominal antigens to normal T cells [24] . Murine keratinocytes, cells 
that have the capacity to express class II m;0or histocompatibility 
complex antigens [25] and ICAM-1 [26] but apparently lack the 
ability to synthesize B7 mRNA or protein, fai l to present antigens to 
T cells but instead induce antigen specific unresponsiveness (clonal 
anergy) [27]. We hypothesize that exposure of LC to ultraviol et 
radiation or chemical fixatives may render them unable to synthe-
size B7 mRNA and protein, and thereby convert LC from potent 
accessory cells into cells that (in conjunction with antigen) induce 
tolerance [28]. Our results do not exclude the possibility that mur-
ine keratinocytes (like human keratinocytes [29 - 31]) express func-
tionall y important costimulatory molecules whose nucleotide se-
quences are distinct from that of B7. 
The present studies indicate that the surface level ofB7 on murine 
fLC and cLC is directly proportional to the level of B7 mRNA 
present, a result that presumably reflects increased B7 mRNA syn-
thesis or enhanced B7 mRNA stability in cLC. It will be of interest 
to identify cytokines or other microenvironmental influences that 
regulate B7 mRNA levels in LC and to determine if mRNAs en-
coding other costimulatory molecules expressed by cLC (including 
ICAM-l and LFA-3) are coordinately controlled. Attempts to study 
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ICAM-1mRNA levels in LC using the techniques described in the 
present study were inconclusive because ICAM-l mRN A was read-
ily detected in keratinocytes, and it was not possible to completely 
deplete keratinocytes from LC-enriched preparations (based on re-
sidual keratin 1 mRNA content). Recently developed methods that 
permit propagation of Langerhans cell-like cells from mouse [32] 
and human peripheral blood [33] and from mouse bone marrow [34] 
may allow these questions to be addressed more directly in future 
experiments. 
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